const h=(e="")=>e==="prevalence"?i():e==="pathophysiology"?t():e==="pathogenesis"?n():e==="causes"?o():e==="pathology"?a():e==="classification"?r():e==="clinical-presentation"?s():e==="examination-findings"?l():e==="investigations"?c():e==="diagnosis"?m():e==="management"?d():e==="treatment-options"?p():e==="protocols"?g():e==="prognosis-outcomes"?u():e==="kenya-context"?y():[{title:"Anemia in Pregnancy - Comprehensive Management",clickableItems:[{text:"ğŸ“Š Prevalence & Epidemiology",sectionId:"prevalence"},{text:"âš¡ Pathophysiology",sectionId:"pathophysiology"},{text:"ğŸ§¬ Pathogenesis",sectionId:"pathogenesis"},{text:"ğŸ” Causes & Etiology",sectionId:"causes"},{text:"ğŸ”¬ Pathology",sectionId:"pathology"},{text:"ğŸ“‹ Classification & Severity",sectionId:"classification"},{text:"ğŸ©º Clinical Presentation",sectionId:"clinical-presentation"},{text:"ğŸ‘©â€âš•ï¸ Examination Findings",sectionId:"examination-findings"},{text:"ğŸ” Investigations",sectionId:"investigations"},{text:"ğŸ¯ Diagnosis",sectionId:"diagnosis"},{text:"ğŸ’Š Management Overview",sectionId:"management"},{text:"ğŸ¥ Treatment Options & Protocols",sectionId:"treatment-options"},{text:"ğŸ“‹ Clinical Protocols",sectionId:"protocols"},{text:"ğŸ“ˆ Prognosis & Outcomes",sectionId:"prognosis-outcomes"},{text:"ğŸ‡°ğŸ‡ª Kenya-Specific Considerations",sectionId:"kenya-context"}]},{title:"Anemia in Pregnancy Overview",points:["ğŸ©¸ **Definition**: Hemoglobin <11.0 g/dL during pregnancy (WHO criteria)","ğŸ“Š **Global Prevalence**: 36-56% of pregnant women worldwide","ğŸŒ **Developing Countries**: Up to 80% prevalence in some regions","âš¡ **Iron Deficiency**: Most common cause (75-95% of cases)","ğŸ¤° **Physiological Changes**: Plasma volume expansion vs red cell mass","ğŸ‘¶ **Fetal Impact**: Growth restriction, prematurity, low birth weight","ğŸ’€ **Maternal Mortality**: Contributes to 20% of maternal deaths"]},{title:"Anemia Classification by Hemoglobin Levels",subsections:[{title:"Severity Classification (WHO 2011)",points:["ğŸŸ¢ **Mild**: 10.0-10.9 g/dL","ğŸŸ¡ **Moderate**: 7.0-9.9 g/dL","ğŸ”´ **Severe**: 4.0-6.9 g/dL","ğŸš¨ **Very Severe**: <4.0 g/dL"]},{title:"Trimester-Specific Cut-offs",points:["ğŸ¥‡ **First Trimester**: <11.0 g/dL","ğŸ¥ˆ **Second Trimester**: <10.5 g/dL","ğŸ¥‰ **Third Trimester**: <11.0 g/dL","ğŸ¤± **Postpartum**: <10.0 g/dL"]},{title:"Treatment Urgency",points:["ğŸŸ¢ **Mild**: Oral iron, dietary counseling","ğŸŸ¡ **Moderate**: Oral/parenteral iron, close monitoring","ğŸ”´ **Severe**: Parenteral iron, consider transfusion","ğŸš¨ **Very Severe**: Immediate transfusion, ICU care"]}]}],i=()=>[{title:"Prevalence and Epidemiology of Anemia in Pregnancy",subsections:[{title:"Global Prevalence",points:["ğŸŒ **Worldwide**: 36-56% of pregnant women affected","ğŸ­ **Developed Countries**: 18-25% prevalence","ğŸŒ¾ **Developing Countries**: 50-80% prevalence","ğŸ“ˆ **Trends**: Declining in some regions, persistent in others","ğŸ’° **Economic Impact**: Billions in healthcare costs annually","ğŸ”„ **Variation**: Wide geographic and demographic variation"]},{title:"Regional Distribution",points:["ğŸŒ **Sub-Saharan Africa**: 60-80% prevalence","ğŸŒ **South Asia**: 50-70% prevalence","ğŸŒ **Latin America**: 30-40% prevalence","ğŸ—ï¸ **Developed World**: 15-25% prevalence","ğŸï¸ **Island Nations**: Variable 20-60%","â„ï¸ **Northern Countries**: Lowest rates 10-20%"]},{title:"Risk Factor Epidemiology",points:["ğŸ‘© **Maternal Age**: Higher in adolescents and >35 years","ğŸ¤° **Parity**: Increased with multiparity","ğŸ“ **Birth Spacing**: <18 months between pregnancies","ğŸ’° **Socioeconomic**: Strong inverse correlation","ğŸ“š **Education**: Lower education higher risk","ğŸ  **Rural vs Urban**: Higher in rural areas"]},{title:"Nutritional Epidemiology",points:["ğŸ”´ **Iron Deficiency**: 75-95% of pregnancy anemia","ğŸƒ **Folate Deficiency**: 5-15% of cases","ğŸ’« **B12 Deficiency**: 2-5% of cases","ğŸ§¬ **Combined Deficiencies**: 20-30% have multiple","ğŸ½ï¸ **Dietary Patterns**: Plant-based diets higher risk","ğŸ’Š **Supplementation**: Programs reduce prevalence 30-50%"]},{title:"Trimester Distribution",points:["ğŸ¥‡ **First Trimester**: 15-25% prevalence","ğŸ¥ˆ **Second Trimester**: 25-40% prevalence","ğŸ¥‰ **Third Trimester**: 35-60% prevalence","ğŸ“ˆ **Progressive**: Increases with gestational age","ğŸ’§ **Hemodilution**: Peak at 28-34 weeks","ğŸ”„ **Recovery**: Partial improvement near term"]},{title:"Severity Distribution",points:["ğŸŸ¢ **Mild**: 60-70% of anemic pregnant women","ğŸŸ¡ **Moderate**: 25-35% of anemic cases","ğŸ”´ **Severe**: 5-15% of anemic cases","ğŸš¨ **Very Severe**: <2% of anemic cases","âš¡ **Geographic**: Severity varies by region","ğŸ¥ **Hospital**: Higher severity in tertiary centers"]}]}],t=()=>[{title:"Pathophysiology of Anemia in Pregnancy",subsections:[{title:"Normal Pregnancy Hematologic Changes",points:["ğŸ“ˆ **Plasma Volume**: Increases 40-50% by 32-34 weeks","ğŸ”´ **Red Cell Mass**: Increases 20-30% in pregnancy","ğŸ’§ **Hemodilution**: Physiological anemia of pregnancy","ğŸ“‰ **Hemoglobin**: Nadir at 28-34 weeks gestation","âš¡ **Cardiac Output**: Increased to compensate","ğŸ”„ **Blood Viscosity**: Decreased, improves circulation"]},{title:"Iron Metabolism in Pregnancy",points:["ğŸ“ˆ **Iron Requirements**: Increase from 1mg to 6-7mg/day","ğŸ¤° **Total Needs**: 1000-1200mg for entire pregnancy","ğŸ‘¶ **Fetal Needs**: 300-400mg transferred to fetus","ğŸ©¸ **Blood Loss**: 200-300mg for delivery","ğŸ”„ **Absorption**: Increases 2-3 fold in pregnancy","ğŸ“‰ **Stores**: Progressive depletion if inadequate intake"]},{title:"Oxygen Transport Physiology",points:["ğŸ« **Oxygen Carrying**: Reduced capacity with low Hb","ğŸ’“ **Cardiac Compensation**: Increased stroke volume, heart rate","ğŸ”„ **Oxygen Extraction**: Enhanced tissue extraction","âš¡ **2,3-DPG**: Increased for better oxygen release","ğŸŒŠ **Blood Flow**: Redistributed to vital organs","ğŸ§  **Autoregulation**: Maintained cerebral perfusion"]},{title:"Maternal Adaptations",points:["ğŸ’“ **Cardiovascular**: High output state","ğŸ« **Respiratory**: Increased minute ventilation","ğŸ«˜ **Renal**: Enhanced erythropoietin production","ğŸƒ **Hepatic**: Altered protein synthesis","ğŸ”„ **Metabolic**: Increased basal metabolic rate","âš¡ **Cellular**: Enhanced glycolysis"]},{title:"Placental Function Impact",points:["ğŸ¤° **Uteroplacental Flow**: Maintained until severe anemia","ğŸ’« **Oxygen Delivery**: Reduced to fetus","ğŸ”„ **Nutrient Transfer**: Iron transport mechanisms","âš¡ **Placental Size**: May increase compensatorily","ğŸŒŠ **Vascular Changes**: Altered placental vascularity","ğŸ§¬ **Gene Expression**: Hypoxia-induced changes"]},{title:"Compensatory Mechanisms",points:["ğŸ”´ **Erythropoiesis**: Increased red cell production","ğŸ’« **Iron Mobilization**: Enhanced iron release from stores","âš¡ **Absorption**: Upregulated intestinal iron uptake","ğŸ”„ **Recycling**: Improved iron recycling from senescent RBCs","ğŸŒŠ **Vascular**: Enhanced cardiovascular function","ğŸ§¬ **Molecular**: HIF pathway activation"]}]}],n=()=>[{title:"Pathogenesis of Anemia in Pregnancy",subsections:[{title:"Iron Deficiency Development",points:["ğŸ“‰ **Store Depletion**: Progressive iron store depletion","âš¡ **Transport Changes**: Reduced transferrin saturation","ğŸ”´ **Erythropoiesis**: Iron-deficient erythropoiesis","ğŸ’« **Enzyme Function**: Reduced iron-containing enzymes","ğŸ”„ **Cellular Function**: Impaired cellular metabolism","ğŸ§¬ **Gene Expression**: Altered iron-related gene expression"]},{title:"Nutritional Deficiency Cascade",points:["ğŸ½ï¸ **Dietary Inadequacy**: Insufficient iron intake","âš¡ **Absorption Issues**: Poor bioavailability","ğŸ”„ **Increased Losses**: Bleeding, parasites","ğŸ’« **Competition**: Other nutrients affecting absorption","ğŸŒŠ **Physiological Needs**: Pregnancy demands exceed supply","ğŸ§¬ **Individual Variation**: Genetic factors in metabolism"]},{title:"Folate Deficiency Mechanisms",points:["ğŸƒ **Increased Demands**: 5-10 fold increase in pregnancy","ğŸ“‰ **Dietary Inadequacy**: Poor folate intake","âš¡ **Absorption**: Malabsorption syndromes","ğŸ’Š **Medications**: Antifolate drugs","ğŸ”„ **Utilization**: Rapid cell division demands","ğŸ§¬ **DNA Synthesis**: Impaired thymidine synthesis"]},{title:"Vitamin B12 Deficiency",points:["ğŸ’« **Dietary Patterns**: Vegetarian/vegan diets","âš¡ **Absorption**: Intrinsic factor deficiency","ğŸ”„ **Transport**: Transcobalamin deficiency","ğŸƒ **Utilization**: Methylcobalamin/adenosylcobalamin","ğŸ§¬ **Metabolism**: Methionine cycle disruption","ğŸŒŠ **Neural**: Myelin synthesis impairment"]},{title:"Chronic Disease Anemia",points:["ğŸ”¥ **Inflammation**: Chronic inflammatory states","âš¡ **Hepcidin**: Increased hepcidin production","ğŸ”’ **Iron Sequestration**: Macrophage iron retention","ğŸ’« **Erythropoietin**: Relative EPO deficiency","ğŸ”„ **Cytokines**: IL-6, TNF-Î±, interferon effects","ğŸ§¬ **Gene Regulation**: Iron homeostasis disruption"]},{title:"Hemoglobinopathy Impact",points:["ğŸ§¬ **Genetic Variants**: Sickle cell, thalassemia","ğŸ”´ **Hemolysis**: Increased red cell destruction","âš¡ **Ineffective Erythropoiesis**: Bone marrow dysfunction","ğŸ’« **Iron Overload**: Paradoxical iron accumulation","ğŸ”„ **Organ Damage**: Secondary organ dysfunction","ğŸŒŠ **Complications**: Vaso-occlusive events"]}]}],o=()=>[{title:"Causes and Etiology of Anemia in Pregnancy",subsections:[{title:"Nutritional Deficiencies (Most Common)",points:["ğŸ”´ **Iron Deficiency**: 75-95% of pregnancy anemia","ğŸƒ **Folate Deficiency**: 5-15% of cases","ğŸ’« **Vitamin B12 Deficiency**: 2-5% of cases","ğŸ§¬ **Combined Deficiencies**: Iron + folate common","âš¡ **Protein Deficiency**: Severe malnutrition","ğŸ”„ **Multiple Micronutrients**: Vitamin A, riboflavin"]},{title:"Blood Loss",points:["ğŸ©¸ **Antepartum Hemorrhage**: Placental abruption, previa","ğŸ’« **Gastrointestinal**: Peptic ulcer, hemorrhoids","ğŸ¦  **Parasitic**: Hookworm, schistosomiasis","âš¡ **Menorrhagia**: Pre-pregnancy heavy periods","ğŸ”„ **Frequent Pregnancies**: Short interpregnancy intervals","ğŸ©¸ **Chronic Bleeding**: Any source of occult blood loss"]},{title:"Hemolytic Anemias",points:["ğŸ§¬ **Sickle Cell Disease**: HbSS, HbSC variants","âš¡ **Thalassemia**: Î± and Î² thalassemia","ğŸ’« **G6PD Deficiency**: Enzyme deficiency","ğŸ”„ **Autoimmune**: Autoimmune hemolytic anemia","ğŸ¦  **Infectious**: Malaria, babesiosis","ğŸ’Š **Drug-Induced**: Medication-related hemolysis"]},{title:"Bone Marrow Disorders",points:["ğŸ§¬ **Aplastic Anemia**: Bone marrow failure","âš¡ **Myelodysplastic Syndrome**: Clonal disorders","ğŸ’« **Leukemia**: Acute or chronic leukemias","ğŸ”„ **Myelofibrosis**: Primary or secondary","ğŸ¯ **Metastatic Disease**: Bone marrow infiltration","ğŸ’Š **Drug-Induced**: Chemotherapy, chloramphenicol"]},{title:"Chronic Diseases",points:["ğŸ«˜ **Chronic Kidney Disease**: EPO deficiency","ğŸ”¥ **Inflammatory Diseases**: SLE, RA, IBD","ğŸ¦  **Chronic Infections**: HIV, tuberculosis","ğŸƒ **Liver Disease**: Chronic hepatitis, cirrhosis","ğŸ’“ **Heart Disease**: Congestive heart failure","ğŸ§¬ **Endocrine**: Hypothyroidism, adrenal insufficiency"]},{title:"Pregnancy-Specific Causes",points:["ğŸ’§ **Hemodilution**: Physiological anemia","ğŸ¤¢ **Hyperemesis Gravidarum**: Poor nutritional intake","ğŸ”„ **Multiple Pregnancy**: Increased demands","âš¡ **Frequent Pregnancies**: Depleted iron stores","ğŸ©¸ **Pregnancy Complications**: HELLP, preeclampsia","ğŸ’« **Gestational Age**: Preterm delivery complications"]}]}],a=()=>[{title:"Pathology of Anemia in Pregnancy",subsections:[{title:"Iron Deficiency Pathology",points:["ğŸ”¬ **Bone Marrow**: Absent iron stores, increased erythroblasts","ğŸ”´ **Red Blood Cells**: Microcytic, hypochromic morphology","âš¡ **Reticulocytes**: Low count initially, increases with treatment","ğŸ’« **Platelets**: Often elevated (thrombocytosis)","ğŸ”„ **White Cells**: Usually normal","ğŸ§¬ **Biochemical**: Low ferritin, high TIBC, low transferrin saturation"]},{title:"Megaloblastic Anemia Pathology",points:["ğŸ”¬ **Bone Marrow**: Megaloblastic changes, nuclear-cytoplasmic dissociation","ğŸ”´ **Red Blood Cells**: Macrocytic, oval macrocytes","âš¡ **Neutrophils**: Hypersegmented neutrophils (>5 lobes)","ğŸ’« **Platelets**: Often decreased (thrombocytopenia)","ğŸ”„ **Reticulocytes**: Low count","ğŸ§¬ **Biochemical**: High LDH, indirect bilirubin"]},{title:"Hemolytic Anemia Features",points:["ğŸ”¬ **Bone Marrow**: Erythroid hyperplasia","ğŸ”´ **Peripheral Smear**: Schistocytes, spherocytes","âš¡ **Reticulocytes**: Markedly elevated","ğŸ’« **Biochemical**: High LDH, low haptoglobin","ğŸ”„ **Bilirubin**: Elevated indirect bilirubin","ğŸ§¬ **Urinalysis**: Hemoglobinuria, hemosiderinuria"]},{title:"Chronic Disease Anemia",points:["ğŸ”¬ **Bone Marrow**: Adequate iron stores, reduced utilization","ğŸ”´ **Morphology**: Normocytic, normochromic initially","âš¡ **Iron Studies**: Low iron, low TIBC, normal/high ferritin","ğŸ’« **Inflammation**: Elevated acute phase reactants","ğŸ”„ **Hepcidin**: Elevated levels","ğŸ§¬ **Erythropoietin**: Relatively low for degree of anemia"]}]}],r=()=>[{title:"Classification of Anemia in Pregnancy",subsections:[{title:"WHO Classification by Severity",points:["ğŸŸ¢ **Mild Anemia**: Hb 10.0-10.9 g/dL","ğŸŸ¡ **Moderate Anemia**: Hb 7.0-9.9 g/dL","ğŸ”´ **Severe Anemia**: Hb 4.0-6.9 g/dL","ğŸš¨ **Very Severe Anemia**: Hb <4.0 g/dL"]},{title:"Morphological Classification",points:["ğŸ”´ **Microcytic (MCV <80 fL)**: Iron deficiency, thalassemia","ğŸ’« **Normocytic (MCV 80-100 fL)**: Chronic disease, acute blood loss","ğŸƒ **Macrocytic (MCV >100 fL)**: B12/folate deficiency","âš¡ **Mixed**: Combined deficiencies"]},{title:"Etiological Classification",points:["ğŸ“‰ **Decreased Production**: Nutritional, bone marrow disorders","ğŸ©¸ **Increased Loss**: Bleeding, hemolysis","ğŸ’§ **Dilutional**: Physiological anemia of pregnancy","ğŸ”„ **Combined**: Multiple mechanisms"]},{title:"Clinical Urgency Classification",points:["ğŸŸ¢ **Non-urgent**: Hb >10 g/dL, asymptomatic","ğŸŸ¡ **Semi-urgent**: Hb 7-10 g/dL, mild symptoms","ğŸ”´ **Urgent**: Hb 4-7 g/dL, symptomatic","ğŸš¨ **Emergency**: Hb <4 g/dL, hemodynamic compromise"]},{title:"Trimester-Specific Classification",points:["ğŸ¥‡ **First Trimester**: Cut-off 11.0 g/dL","ğŸ¥ˆ **Second Trimester**: Cut-off 10.5 g/dL (hemodilution peak)","ğŸ¥‰ **Third Trimester**: Cut-off 11.0 g/dL","ğŸ¤± **Postpartum**: Cut-off 10.0 g/dL"]},{title:"Response-Based Classification",points:["âœ… **Treatment Responsive**: Appropriate Hb rise","ğŸ”„ **Slow Response**: Suboptimal but improving","âŒ **Non-responsive**: No improvement despite treatment","âš¡ **Refractory**: Worsening despite optimal therapy"]}]}],s=()=>[{title:"Clinical Presentation of Anemia in Pregnancy",subsections:[{title:"General Symptoms",points:["ğŸ˜´ **Fatigue**: Progressive tiredness, weakness","ğŸ« **Dyspnea**: Shortness of breath on exertion","ğŸ’“ **Palpitations**: Awareness of rapid heartbeat","ğŸ¤• **Headache**: Frequent headaches","ğŸ’« **Dizziness**: Lightheadedness, near-fainting","ğŸ§  **Concentration**: Difficulty concentrating"]},{title:"Cardiovascular Symptoms",points:["ğŸ’“ **Tachycardia**: Resting heart rate >100 bpm","âš¡ **Exercise Intolerance**: Reduced exercise capacity","ğŸ« **Orthopnea**: Difficulty breathing when lying flat","ğŸ’« **Chest Pain**: Atypical chest discomfort","ğŸ”„ **Syncope**: Fainting episodes","ğŸŒŠ **Peripheral Edema**: Ankle swelling"]},{title:"Neurological Symptoms",points:["ğŸ§  **Cognitive Impairment**: Memory problems, confusion","âš¡ **Restless Legs**: Urge to move legs","ğŸ’« **Mood Changes**: Irritability, depression","ğŸ”„ **Sleep Disturbances**: Insomnia, frequent waking","ğŸŒŠ **Peripheral Neuropathy**: Tingling, numbness (B12 deficiency)","ğŸ¯ **Visual Changes**: Blurred vision"]},{title:"Gastrointestinal Symptoms",points:["ğŸ½ï¸ **Poor Appetite**: Reduced food intake","ğŸ¤¢ **Nausea**: Persistent nausea","ğŸ‘… **Taste Changes**: Metallic taste, pica","ğŸ’© **Bowel Changes**: Constipation or diarrhea","âš¡ **Epigastric Pain**: Upper abdominal discomfort","ğŸ”„ **Weight Loss**: Unintentional weight loss"]},{title:"Obstetric-Specific Symptoms",points:["ğŸ¤° **Reduced Fetal Movements**: Decreased fetal activity","âš¡ **Uterine Irritability**: Increased Braxton Hicks","ğŸ’« **Poor Weight Gain**: Inadequate maternal weight gain","ğŸ”„ **Pregnancy Complications**: Increased infection risk","ğŸŒŠ **Labor Issues**: Prolonged labor, poor progress","ğŸ©¸ **Bleeding Risk**: Increased hemorrhage risk"]},{title:"Severity-Related Symptoms",points:["ğŸŸ¢ **Mild**: Often asymptomatic or mild fatigue","ğŸŸ¡ **Moderate**: Fatigue, dyspnea on exertion, palpitations","ğŸ”´ **Severe**: Rest dyspnea, severe fatigue, chest pain","ğŸš¨ **Very Severe**: Syncope, confusion, cardiac failure"]}]}],l=()=>[{title:"Examination Findings in Anemia in Pregnancy",subsections:[{title:"General Examination",points:["ğŸ”´ **Pallor**: Conjunctival, palmar, nail bed pallor","ğŸ’“ **Tachycardia**: Resting HR >100 bpm","ğŸ« **Tachypnea**: Increased respiratory rate","ğŸ’§ **Edema**: Peripheral edema in severe cases","âš–ï¸ **Weight**: Poor weight gain pattern","ğŸŒ¡ï¸ **Temperature**: Usually normal"]},{title:"Cardiovascular Examination",points:["ğŸ’“ **Heart Rate**: Tachycardia, regular rhythm","ğŸ”Š **Heart Sounds**: Systolic flow murmur common","ğŸ“ˆ **Blood Pressure**: May be low in severe cases","âš¡ **JVP**: Usually normal unless heart failure","ğŸ«€ **Gallop**: S3 gallop in severe anemia","ğŸ’« **Peripheral Pulses**: Bounding pulse"]},{title:"Respiratory Examination",points:["ğŸ« **Inspection**: Tachypnea, use of accessory muscles","ğŸ‘‚ **Auscultation**: Usually clear, crepitations if failure","âš¡ **Expansion**: Normal chest expansion","ğŸ’« **Percussion**: Normal resonance","ğŸ”„ **Effort**: Increased work of breathing","ğŸŒŠ **Oxygen Saturation**: Usually normal"]},{title:"Abdominal Examination",points:["ğŸ¤° **Uterine Size**: Appropriate for gestational age","ğŸ‘‚ **Fetal Heart**: May be tachycardic","ğŸƒ **Splenomegaly**: May indicate hemolysis","âš¡ **Hepatomegaly**: Rare, suggests other pathology","ğŸ’« **Ascites**: Only in severe heart failure","ğŸ”„ **Bowel Sounds**: Usually normal"]},{title:"Specific Signs by Etiology",points:["ğŸ’… **Iron Deficiency**: Koilonychia, brittle nails","ğŸ‘… **B12 Deficiency**: Glossitis, peripheral neuropathy","ğŸŸ¡ **Folate Deficiency**: Glossitis, mood changes","âš¡ **Hemolysis**: Jaundice, splenomegaly","ğŸ”„ **Chronic Disease**: Signs of underlying condition","ğŸ§¬ **Hemoglobinopathy**: Ethnic features, organ damage"]},{title:"Severity Assessment Signs",points:["ğŸŸ¢ **Mild**: Minimal pallor, normal vital signs","ğŸŸ¡ **Moderate**: Obvious pallor, mild tachycardia","ğŸ”´ **Severe**: Marked pallor, tachycardia, flow murmur","ğŸš¨ **Very Severe**: Shock, confusion, heart failure"]}]}],c=()=>[{title:"Investigations for Anemia in Pregnancy",subsections:[{title:"First-Line Investigations",points:["ğŸ©¸ **Complete Blood Count**: Hb, Hct, MCV, MCH, MCHC","ğŸ”¬ **Blood Film**: Red cell morphology, inclusions","âš¡ **Reticulocyte Count**: Bone marrow response","ğŸ’« **Iron Studies**: Serum iron, TIBC, transferrin saturation","ğŸ”„ **Ferritin**: Iron stores assessment","ğŸ§¬ **Basic Chemistry**: LDH, bilirubin"]},{title:"Iron Status Assessment",points:["ğŸ”´ **Serum Ferritin**: <15 Î¼g/L indicates iron deficiency","âš¡ **Transferrin Saturation**: <16% suggests iron deficiency","ğŸ’« **Serum Iron**: Low in iron deficiency","ğŸ”„ **TIBC**: Elevated in iron deficiency","ğŸŒŠ **Soluble Transferrin Receptor**: Elevated when deficient","ğŸ§¬ **Hepcidin**: Research tool, reflects iron status"]},{title:"Vitamin Deficiency Tests",points:["ğŸƒ **Serum Folate**: <3 ng/mL indicates deficiency","ğŸ”„ **Red Cell Folate**: Better indicator of tissue stores","ğŸ’« **Vitamin B12**: <200 pg/mL suggests deficiency","âš¡ **Homocysteine**: Elevated in B12/folate deficiency","ğŸ§¬ **Methylmalonic Acid**: Specific for B12 deficiency","ğŸŒŠ **Intrinsic Factor Antibodies**: Pernicious anemia"]},{title:"Hemolysis Work-up",points:["ğŸ“ˆ **LDH**: Elevated in hemolysis","ğŸ“‰ **Haptoglobin**: Decreased in hemolysis","ğŸŸ¡ **Indirect Bilirubin**: Elevated","ğŸ”¬ **Direct Coombs**: Autoimmune hemolysis","âš¡ **G6PD Levels**: Enzyme deficiency screen","ğŸ§¬ **Hemoglobin Electrophoresis**: Hemoglobinopathies"]},{title:"Specialized Tests",points:["ğŸ¦  **Stool Parasites**: Hookworm, other parasites","ğŸ©¸ **Occult Blood**: GI bleeding assessment","ğŸ§¬ **Genetic Testing**: Thalassemia, sickle cell","âš¡ **Bone Marrow**: If diagnosis unclear","ğŸ’« **Iron Absorption Test**: Malabsorption assessment","ğŸ”„ **EPO Levels**: Chronic kidney disease"]},{title:"Monitoring Parameters",points:["ğŸ“Š **Serial CBC**: Weekly initially, then monthly","ğŸ”„ **Reticulocyte Response**: Peaks at 7-10 days","âš¡ **Iron Studies**: Repeat after 4-6 weeks treatment","ğŸ’« **Folate/B12**: Monitor levels during treatment","ğŸŒŠ **Clinical Response**: Symptom improvement","ğŸ§¬ **Compliance**: Treatment adherence assessment"]}]}],m=()=>[{title:"Diagnosis of Anemia in Pregnancy",subsections:[{title:"Diagnostic Criteria",points:["ğŸ©¸ **Hemoglobin Cut-off**: <11.0 g/dL (WHO criteria)","ğŸ“Š **Severity Assessment**: Mild, moderate, severe classification","ğŸ”¬ **Morphological**: MCV classification (micro/normo/macro)","âš¡ **Functional**: Tissue iron deficiency markers","ğŸ’« **Etiological**: Underlying cause identification","ğŸ”„ **Response**: Treatment response assessment"]},{title:"Iron Deficiency Diagnosis",points:["ğŸ”´ **Ferritin <15 Î¼g/L**: Diagnostic in pregnancy","âš¡ **Transferrin Saturation <16%**: Functional deficiency","ğŸ’« **MCV <80 fL**: Microcytic anemia","ğŸ”„ **Hypochromic**: Pale red blood cells","ğŸŒŠ **High TIBC**: >400 Î¼g/dL","ğŸ§¬ **Low Serum Iron**: <60 Î¼g/dL"]},{title:"Folate Deficiency Diagnosis",points:["ğŸƒ **Serum Folate <3 ng/mL**: Indicates deficiency","ğŸ“ˆ **MCV >100 fL**: Macrocytic anemia","âš¡ **Hypersegmented Neutrophils**: >5% with >5 lobes","ğŸ’« **High Homocysteine**: >15 Î¼mol/L","ğŸ”„ **Low Red Cell Folate**: <150 ng/mL","ğŸŒŠ **Normal B12**: Excludes combined deficiency"]},{title:"B12 Deficiency Diagnosis",points:["ğŸ’« **Serum B12 <200 pg/mL**: Suggests deficiency","ğŸ“ˆ **MCV >100 fL**: Macrocytic anemia","ğŸ§¬ **High Methylmalonic Acid**: >0.4 Î¼mol/L","âš¡ **High Homocysteine**: >15 Î¼mol/L","ğŸ”„ **Neurological Signs**: Peripheral neuropathy","ğŸŒŠ **Intrinsic Factor Antibodies**: Pernicious anemia"]},{title:"Differential Diagnosis",points:["ğŸ”„ **Physiological Anemia**: Hemodilution of pregnancy","ğŸ¦  **Chronic Disease**: Inflammation markers elevated","ğŸ§¬ **Hemoglobinopathy**: Electrophoresis abnormal","âš¡ **Hemolysis**: LDH high, haptoglobin low","ğŸ’« **Bone Marrow Disease**: Pancytopenia, abnormal cells","ğŸŒŠ **Combined Deficiencies**: Multiple nutrient deficits"]},{title:"Diagnostic Algorithm",points:["ğŸ“Š **Step 1**: Confirm anemia (Hb <11.0 g/dL)","ğŸ”¬ **Step 2**: Assess morphology (MCV classification)","âš¡ **Step 3**: Iron studies (ferritin, transferrin saturation)","ğŸ’« **Step 4**: Vitamin levels (B12, folate)","ğŸ”„ **Step 5**: Hemolysis screen if indicated","ğŸŒŠ **Step 6**: Specialized tests if diagnosis unclear"]}]}],d=()=>[{title:"Management Overview of Anemia in Pregnancy",subsections:[{title:"General Principles",points:["ğŸ¯ **Identify Cause**: Determine underlying etiology","âš¡ **Assess Severity**: Classify mild, moderate, severe","ğŸ’Š **Specific Treatment**: Target identified deficiency","ğŸ”„ **Monitor Response**: Serial hemoglobin monitoring","ğŸ¤° **Maternal Safety**: Ensure maternal well-being","ğŸ‘¶ **Fetal Monitoring**: Assess fetal growth and well-being"]},{title:"Treatment Selection Criteria",points:["ğŸ“Š **Severity-Based**: Mild (oral), severe (parenteral/transfusion)","â° **Gestational Age**: Consider proximity to delivery","ğŸ’Š **Tolerance**: Oral tolerance, side effects","ğŸ”„ **Compliance**: Patient adherence capability","âš¡ **Urgency**: Emergency vs routine treatment","ğŸŒŠ **Comorbidities**: Other medical conditions"]},{title:"Goals of Treatment",points:["ğŸ“ˆ **Hemoglobin Target**: >11.0 g/dL by 36 weeks","âš¡ **Symptom Relief**: Improve maternal symptoms","ğŸ”„ **Prevent Complications**: Reduce morbidity risk","ğŸ‘¶ **Optimize Fetal Outcomes**: Prevent IUGR, prematurity","ğŸ©¸ **Prepare for Delivery**: Minimize hemorrhage risk","ğŸ’Š **Restore Iron Stores**: Replenish body iron stores"]},{title:"Monitoring Strategy",points:["ğŸ“Š **Baseline**: Pre-treatment CBC, iron studies","ğŸ”„ **Early Response**: Reticulocyte count at 7-10 days","ğŸ“ˆ **Weekly CBC**: First 2-4 weeks of treatment","ğŸ’« **Monthly Follow-up**: Once stable response established","âš¡ **Iron Studies**: Repeat at 4-6 weeks","ğŸ¯ **Delivery Preparation**: Hb check at 36 weeks"]},{title:"Treatment Failure Assessment",points:["âŒ **No Response**: <1 g/dL rise in 3-4 weeks","ğŸ”„ **Poor Compliance**: Inadequate medication adherence","ğŸ’Š **Malabsorption**: GI disorders affecting absorption","ğŸ©¸ **Ongoing Losses**: Continued bleeding","âš¡ **Wrong Diagnosis**: Misidentified cause","ğŸ§¬ **Other Deficiencies**: Combined nutrient deficits"]},{title:"Multidisciplinary Approach",points:["ğŸ‘©â€âš•ï¸ **Obstetrician**: Primary pregnancy care","ğŸ©¸ **Hematologist**: Complex cases, non-response","ğŸ½ï¸ **Dietitian**: Nutritional counseling","ğŸ’Š **Pharmacist**: Medication counseling","ğŸ¥ **Anesthesiologist**: Delivery planning","ğŸ‘¶ **Neonatologist**: If preterm delivery risk"]}]}],p=()=>[{title:"Treatment Options and Hemoglobin Response Rates",subsections:[{title:"Oral Iron Therapy",points:["ğŸ’Š **Ferrous Sulfate**: 325mg (65mg elemental) TID","âš¡ **Ferrous Fumarate**: 200mg (66mg elemental) TID","ğŸ’« **Ferrous Gluconate**: 300mg (36mg elemental) TID","ğŸ”„ **Polysaccharide Iron**: 150mg elemental daily","ğŸ· **Tothema (Iron Fumarate)**: 50mg elemental BD","ğŸ’ **Fast-Acting Formulations**: Chelated iron, heme iron","ğŸ“ˆ **Hb Rise Rate**: 1-2 g/dL per month (standard)","âš¡ **Tothema Specific**: 1.5-2.2 g/dL per month","â° **Response Time**: 2-4 weeks for initial response","ğŸ¯ **Fast-Acting Response**: 10-14 days for initial rise"]},{title:"Parenteral Iron Therapy",points:["ğŸ’‰ **Iron Sucrose**: 200mg IV 2-3 times weekly","âš¡ **Ferric Carboxymaltose**: 500-1000mg IV single dose","ğŸ’« **Iron Dextran**: 100mg IM daily (rarely used)","ğŸ”„ **Ferric Gluconate**: 125mg IV 2-3 times weekly","ğŸ“ˆ **Hb Rise Rate**: 2-4 g/dL per month","â° **Response Time**: 1-2 weeks for initial response","ğŸ¯ **Iron Sucrose Specific**: 1.5-2.5 g/dL rise per month","âš¡ **Iron Sucrose Response**: 7-14 days for initial rise"]},{title:"Blood Transfusion",points:["ğŸ©¸ **Packed RBCs**: 1 unit raises Hb by ~1 g/dL","âš¡ **Immediate Effect**: Immediate hemoglobin rise","ğŸ’« **Indications**: Hb <7 g/dL or symptomatic <8 g/dL","ğŸ”„ **Emergency**: Hb <4 g/dL or hemodynamic instability","ğŸ¯ **Target**: Hb 8-10 g/dL post-transfusion","â° **Duration**: Effect lasts 3-4 weeks without treatment"]},{title:"Nutritional Management",points:["ğŸ¥© **Iron-Rich Foods**: Red meat, liver, fortified cereals","ğŸŠ **Vitamin C**: Enhances iron absorption","ğŸ¥¬ **Folate-Rich**: Green leafy vegetables, fortified grains","ğŸŸ **B12 Sources**: Animal products, fortified foods","ğŸ“ˆ **Hb Rise Rate**: 0.5-1 g/dL per month","â° **Response Time**: 4-8 weeks for measurable change"]},{title:"Combination Therapy",points:["ğŸ’Š **Iron + Folate**: Standard combination therapy","âš¡ **Iron + B12**: For combined deficiencies","ğŸ’« **Oral + Parenteral**: Severe cases, poor tolerance","ğŸ”„ **Transfusion + Iron**: Emergency stabilization + stores","ğŸ“ˆ **Hb Rise Rate**: 2-3 g/dL per month","â° **Response Time**: 1-2 weeks initial, sustained over months"]},{title:"Treatment Response Comparison",points:["ğŸ¥‡ **Fastest**: Blood transfusion (immediate)","ğŸ¥ˆ **Rapid**: Parenteral iron (1-2 weeks)","ğŸ¥‰ **Moderate**: Oral iron (2-4 weeks)","ğŸ¥‡ **Most Sustained**: Parenteral iron therapy","ğŸ’° **Most Cost-Effective**: Oral iron therapy","ğŸ¥ **Safest**: Oral iron (fewest complications)"]}]}],g=()=>[{title:"Clinical Protocols for Anemia Management in Pregnancy",subsections:[{title:"Mild Anemia Protocol (Hb 10.0-10.9 g/dL)",points:["ğŸ’Š **Treatment**: Oral iron 65mg elemental TID","ğŸŠ **Enhancers**: Vitamin C 200mg with each dose","ğŸ”„ **Follow-up**: CBC at 4 weeks, then monthly","ğŸ“ˆ **Expected Response**: 1-2 g/dL rise per month","âš¡ **Duration**: Continue until Hb >11 g/dL + 3 months","ğŸ¯ **Target**: Achieve Hb >11 g/dL by 36 weeks"]},{title:"Moderate Anemia Protocol (Hb 7.0-9.9 g/dL)",points:["ğŸ’‰ **First Choice**: Parenteral iron therapy","âš¡ **Iron Sucrose**: 200mg IV 3 times weekly","ğŸ”„ **Alternative**: High-dose oral iron if parenteral unavailable","ğŸ“Š **Monitoring**: CBC weekly for 4 weeks, then biweekly","ğŸ“ˆ **Expected Response**: 2-4 g/dL rise per month","ğŸ¥ **Setting**: Outpatient with close monitoring"]},{title:"Severe Anemia Protocol (Hb 4.0-6.9 g/dL)",points:["ğŸ¥ **Admission**: Hospital admission for monitoring","ğŸ’‰ **Parenteral Iron**: Iron sucrose 200mg IV daily","ğŸ©¸ **Consider Transfusion**: If symptomatic or Hb <5 g/dL","ğŸ“Š **Daily Monitoring**: Daily CBC for first week","âš¡ **Cardiology**: Consider echo if heart failure signs","ğŸ¯ **Target**: Hb >8 g/dL before discharge"]},{title:"Very Severe Anemia Protocol (Hb <4.0 g/dL)",points:["ğŸš¨ **Emergency**: Immediate hospital admission","ğŸ©¸ **Blood Transfusion**: 2-4 units PRBC stat","ğŸ’“ **ICU**: Consider ICU if hemodynamic instability","ğŸ”„ **Slow Transfusion**: 1 unit over 4 hours max","ğŸ’‰ **Iron Therapy**: Start parenteral iron post-transfusion","ğŸ¯ **Target**: Hb 8-10 g/dL, avoid over-transfusion"]},{title:"Iron Sucrose Administration Protocol",points:["ğŸ’‰ **Dose**: 200mg (5mL) in 100mL normal saline","â° **Infusion Time**: Over 30 minutes","ğŸ”„ **Frequency**: 3 times per week","ğŸ“Š **Total Dose**: Calculate using Ganzoni formula","âš¡ **Monitoring**: Observe for 30 minutes post-infusion","ğŸ¯ **Maximum**: 600mg per week","ğŸ“ˆ **Hb Rise Rate**: 1.5-2.5 g/dL per month","â° **Initial Response**: 7-10 days for reticulocytosis","ğŸ”„ **Peak Response**: 2-3 weeks for maximum effect"]},{title:"Transfusion Protocol",points:["ğŸ©¸ **Indications**: Hb <7 g/dL or symptomatic <8 g/dL","ğŸ§ª **Pre-transfusion**: Type & screen, CBC, consent","âš¡ **Rate**: 1 unit over 2-4 hours","ğŸ“Š **Monitoring**: Vital signs q15min x 1hr, then hourly","ğŸ”„ **Post-transfusion**: CBC 6 hours after completion","ğŸ¯ **Target**: Hb 8-10 g/dL (avoid >10 g/dL)"]}]}],u=()=>[{title:"Prognosis and Outcomes in Anemia During Pregnancy",subsections:[{title:"Maternal Outcomes with Treatment",points:["âœ… **Mild Anemia**: Excellent prognosis with oral iron","ğŸ“ˆ **Moderate Anemia**: Good outcomes with parenteral iron","ğŸ”„ **Severe Anemia**: Requires intensive treatment, good recovery","âš¡ **Very Severe**: Higher morbidity, but recoverable","ğŸ’Š **Compliance**: Outcomes depend on treatment adherence","ğŸ”„ **Recurrence**: Low with adequate iron stores"]},{title:"Fetal and Neonatal Outcomes",points:["ğŸ‘¶ **Birth Weight**: Improved with anemia correction","â° **Gestational Age**: Reduced preterm delivery risk","ğŸ§  **Neurodevelopment**: Better cognitive outcomes","ğŸ”„ **Perinatal Mortality**: Significant reduction","ğŸ“ˆ **APGAR Scores**: Higher with treated anemia","ğŸ’Š **Iron Stores**: Better neonatal iron status"]},{title:"Long-term Maternal Health",points:["ğŸ’“ **Cardiovascular**: Reduced long-term CVD risk","ğŸ§  **Cognitive Function**: Improved memory, concentration","âš¡ **Energy Levels**: Sustained improvement","ğŸ”„ **Future Pregnancies**: Better outcomes","ğŸ’Š **Iron Stores**: Maintained with adequate treatment","ğŸ¯ **Quality of Life**: Significant improvement"]},{title:"Treatment Response Rates",points:["ğŸ’Š **Oral Iron**: 70-80% achieve target Hb","ğŸ’‰ **Parenteral Iron**: 90-95% achieve target Hb","ğŸ©¸ **Transfusion**: 100% immediate response","ğŸ”„ **Combination**: 95% achieve and maintain target","âš¡ **Non-response**: 5-10% require investigation","ğŸ“ˆ **Sustained Response**: 85% maintain Hb >11 g/dL"]},{title:"Complications Prevention",points:["ğŸ©¸ **Postpartum Hemorrhage**: 50% reduction in risk","ğŸ¦  **Infections**: Reduced puerperal sepsis","ğŸ’“ **Heart Failure**: Prevention of high-output failure","âš¡ **Preterm Labor**: 30% reduction in preterm delivery","ğŸ‘¶ **IUGR**: Improved fetal growth patterns","ğŸ”„ **Maternal Mortality**: Significant reduction"]},{title:"Economic Impact",points:["ğŸ’° **Healthcare Costs**: Reduced overall costs","ğŸ¥ **Hospitalizations**: Fewer admissions","âš¡ **Productivity**: Improved maternal productivity","ğŸ”„ **Long-term Savings**: Reduced chronic disease burden","ğŸ’Š **Treatment Costs**: Cost-effective interventions","ğŸ¯ **Prevention**: Most cost-effective approach"]}]}],y=()=>[{title:"Kenya-Specific Considerations for Anemia in Pregnancy",subsections:[{title:"Epidemiology in Kenya",points:["ğŸ“Š **Prevalence**: 55-75% of pregnant women","ğŸŒ **Regional Variation**: Higher in western regions","ğŸ¦  **Malaria**: Major contributing factor","ğŸª± **Helminth Infections**: Hookworm, schistosomiasis","ğŸ’° **Poverty**: Strong association with malnutrition","ğŸ¥ **Urban vs Rural**: Higher rural prevalence"]},{title:"Specific Risk Factors",points:["ğŸ¦Ÿ **Malaria Endemic**: Year-round transmission in many areas","ğŸª± **Soil-transmitted Helminths**: 30-60% prevalence","ğŸ½ï¸ **Food Insecurity**: Limited access to iron-rich foods","ğŸŒ¾ **Dietary Patterns**: Predominantly plant-based diets","ğŸ‘¶ **High Parity**: Grand multiparous women","ğŸ“š **Education**: Limited health literacy"]},{title:"Healthcare System Challenges",points:["ğŸ¥ **Limited Resources**: Shortage of laboratories","ğŸ’‰ **Parenteral Iron**: Limited availability","ğŸ©¸ **Blood Banking**: Inadequate blood supply","ğŸš— **Transport**: Poor roads, limited ambulances","ğŸ’° **Cost**: High cost relative to income","ğŸ‘¨â€âš•ï¸ **Staffing**: Shortage of trained personnel"]},{title:"Adapted Management Strategies",points:["ğŸ’Š **Iron/Folate**: Universal supplementation program","ğŸ¦Ÿ **IPTp**: Intermittent preventive treatment for malaria","ğŸª± **Deworming**: Routine anthelmintic treatment","ğŸ¥ **Point-of-Care**: Hemocue testing","ğŸ“± **Mobile Health**: SMS reminders for compliance","ğŸ‘¥ **Community Health**: CHW involvement"]},{title:"National Programs",points:["ğŸ’Š **Free Iron/Folate**: Government-provided supplements","ğŸ¦Ÿ **Malaria Control**: LLINs, IPTp programs","ğŸª± **Deworming**: School and community-based programs","ğŸ½ï¸ **Food Fortification**: Iron fortification of maize flour","ğŸ“š **Health Education**: Nutrition counseling programs","ğŸ¥ **Health System**: Focused antenatal care"]},{title:"Quality Improvement Initiatives",points:["ğŸ“Š **Data Systems**: Electronic health records","ğŸ“š **Training**: Healthcare worker capacity building","ğŸ”„ **Quality Audits**: Regular performance reviews","ğŸ¯ **Guidelines**: Locally adapted protocols","ğŸ’° **Financing**: Health insurance expansion","ğŸ¤ **Partnerships**: NGO collaboration"]},{title:"Research Priorities",points:["ğŸ¦Ÿ **Malaria-Anemia**: Interaction mechanisms","ğŸª± **Helminth Burden**: Impact on iron status","ğŸ’Š **Local Formulations**: Culturally acceptable supplements","ğŸ½ï¸ **Dietary Interventions**: Food-based approaches","ğŸ“± **Technology**: Mobile health solutions","ğŸ’° **Economic Evaluation**: Cost-effectiveness studies"]}]}];export{h as getAnemiaPregnancyContent};
